In a challenging year for Biomea Fusion, the company's stock has tumbled to a 52-week low, touching down at $3.58. This latest price level reflects a precipitous drop of 79.63% over the past year, ...

Rocket Pharmaceuticals, Inc. (RCKT) stock has experienced a significant downturn, touching a 52-week low of $9.76. According to InvestingPro data, the stock has declined nearly 9% in the past week and ...